Bioequivalence trials, intersectio–union tests and equivalence confidence sets

Statistical Science

Volumn 11, Issue 4, 1996, Pages 283-302

  Berger, Roger L ^a   Hsu, Jason C ^b  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Bioavailability; Bioequivalence; Confidence interval; Equivalence test; Hypothesis test; Intersection union; Level; Pharmacokinetic; Size; Unbiased

Indexed keywords

EID: 0043005476     PISSN: 08834237     EISSN: None     Source Type: Journal    
DOI: 10.1214/ss/1032280304     Document Type: Article

References (61)

1. Anderson, S. (1993). Individual bioequivalence: a problem of switchability (with discussion). Biopharmaceutical Report 2 1-11.
2. Anderson, S. and Hauck, W. W. (1983). A new procedure for testing equivalence in comparative bioavailability and other clinical trials. Comm. Statist. Theory Methods 12 2663-2692.
3. Anderson, S. and Hauck, W. W. (1985). Letter to the Editor. Biometrics 41 561-563.
4. Anderson, S. and Hauck, W. W. (1990). Consideration of individual bioequivalence. Journal of Pharmacokinetics and Biopharmaceutics 18 259-273.
5. Berger, R. L. (1982). Multiparameter hypothesis testing and acceptance sampling. Technometrics 24 295-300.
6. Berger, R. L. (1989). Uniformly more powerful tests for hypotheses concerning linear inequalities and normal means. J. Amer. Statist. Assoc. 84 192-199.
7. Bofinger, E. (1985). Expanded confidence intervals. Comm. Statist. Theory Methods 14 1849-1864.
8. Bofinger, E. (1992). Expanded confidence intervals, one-sided tests, and equivalence testing. Journal of Biopharmaceutical Statistics 2 181-188.
9. Brown, L. D., Casella, G. and Hwang, J. T. G. (1995a). Optimal confidence sets, bioequivalence, and the limaçon of Pascal. J Amer. Statist. Assoc. 90 880-889.
10. Brown, L. D., Hwang, J. T. G. and Munk, A. (1995b). An unbiased test for the bioequivalence problem. Technical report, Cornell Univ.
11. Casella, G. and Berger, R. L. (1990). Statistical Inference. Duxbury, Belmont, CA.
12. Chow, S.-C. and Liu, J.-P. (1992). Design and Analysis of Bioavailability and Bioequivalence Studies. Dekker, New York.
13. Chow, S.-C. and Shao, J. (1990). An alternative approach for the assessment of bioequivalence between two formulations of a drug. Biometrical J. 32 969-976.
14. Diletti, E., Hauschke, D. and Steinijans, V. W. (1991). Sample size determination for bioequivalence assessment by means of confidence intervals. International Journal of Clinical Pharmacology, Therapy and Toxicology 29 1-8.
15. EC-GCP (1993). Biostatistical Methodology in Clinical Trials in Applications for Marketing Authorization for Medical Products. CPMP Working Party on Efficacy of Medical Products, Commission of the European Communities, Brussels. (Draft guideline edition.)
16. FDA (1987). Guideline for Submitting Documentation for Stability Studies of Human Drugs and Biologics. Center for Drugs and Biologics, Food and Drug Administration, Rockville, MD.
17. FDA (1992a). Bioavailability and bioequivalence requirements. In U.S. Code of Federal Regulations 21, Chapter 320. U.S. Government Printing Office, Washington, D.C.
18. Fieller, E. (1954). Some problems in interval estimation. J Roy. Statist. Soc. Ser. B 16 175-185.
19. Fieller, E. C. (1940). The biological standardisation of insulin. J. Roy. Statist. Soc. Supplement 7 1-64.
20. HAUCK, W. W. and ANDERSON, S. (1992). Types of bioequivalence and related statistical considerations. International Journal of Clinical Pharmacology, Therapy and Toxicology 30 181-187.
21. Hauck, W. W., Hyslop, T., Anderson, S., Bois, F. Y. and Tozer, T. N. (1995). Statistical and regulatory considerations for multiple measures in bioequivalence testing. Clinical Research and Regulatory Affairs 12 249-265.
22. Hauschke, D., Steinijans, V. W. and Diletti E. (1990). A distribution-free procedure for the statistical analysis of bioequivalence studies. International Journal of Clinical Pharmacology, Therapy and Toxicology 28 72-78.
23. Hayter, A. J. and HSU, J. C. (1994). On the relationship between stepwise decision procedures and confidence sets. J. Amer. Statist. Assoc. 89 128-136.
24. HSU, J. C. (1984). Constrained two-sided simultaneous confidence intervals for multiple comparisons with the best. Ann. Statist. 12 1136-1144.
25. HSU, J. C. (1996). Multiple Comparisons. Chapman and Hall, London.
26. Hsu, J. C., Hwang, J. T. G., Liu, H.-K. and Ruberg, S. J. (1994). Confidence intervals associated with tests for bioequivalence. Biometrika 81 103-114.
27. JUSKEVICH, J. C. and Guyer, C. G. (1990). Bovine growth hormone: human food safety evaluation. Science 249 875-884.
28. Kinsella, A. (1989). Bootstrapping a bioequivalence measure. The Statistician 38 175-179.
29. LEHMANN, E. L. (1959). Testing Statistical Hypothesis. Wiley, New York.
30. LEHMANN, E. L. (1986). Testing Statistical Hypothesis, 2nd ed. Wiley, New York.
31. Liu, H. and Berger, R. L. (1995). Uniformly more powerful, onesided tests for hypotheses about linear inequalities. Ann. Statist. 23 55-72.
32. Liu, J.-P. and Chow, S.-C. (1992). On the assessment of variability in bioavailability/bioequivalence studies. Comm. Statist. Theory Methods 21 2591-2607.
33. Liu, J.-P. and Weng, C.-S. (1995). Bias of two one-sided tests procedures in assessment of bioequivalence. Statistics in Medicine 14 853-861.
34. LOCKE, C. S. (1984). An exact confidence interval from untransformed data for the ratio of two formulation means. Journal of Pharmacokinetics and Biopharmaceutics 12 649-655.
35. MANDALLAZ, D. and Mau, J. (1981). Comparison of different methods for decision-making in bioequivalence assessment. Biometrics 20 213-222.
36. Martin AndrEs, A. (1990). On testing for bioequivalence. Biometrical J. 32 125-126.
37. METZLER, C. M. (1991). Sample sizes for bioequivalence studies. Statistics in Medicine 10 961-970.
38. MUller-Cohrs, J. (1991). An improvement of the Westlake symmetric confidence interval. Biometrical J. 33 357-360.
39. Munk, A. (1993). An improvement on commonly used tests in bioequivalence assessment. Biometrics 49 1225-1230.
40. PATEL, H. I. and Gupta, G. D. (1984). A problem of equivalence in clinical trials. Biometrical J. 26 471-474.
41. PRATT, J. W. (1961). Length of confidence intervals. J. Amer. Statist. Assoc. 56 541-567.
42. Rocke, D. M. (1984). On testing for bioequivalence. Biometrics 40 225-230.
43. Ruberg, S. J. and HSU, J. C. (1992). Multiple comparison procedures for pooling batches in stability studies. Technometrics 34 465-472.
44. SASABUCHi, S. (1980). A test of a multivariate normal mean with composite hypotheses determined by linear inequalities. Biometrika 67 429-439.
45. SASABUCHi, S. (1988a). A multivariate one-sided test with composite hypotheses when the covariance matrix is completely unknown. Mem. Fac. Sci. Kyushu Univ. Ser. A 42 37-46.
46. SASABUCHi, S. (1988b). A multivariate test with composite hypotheses determined by linear inequalities when the covariance matrix has an unknown scale factor. Mem. Fac. Sci. Kyushu Univ. Ser A 42 9-19.
47. SCHALL, R. and LUSS, G. H. (1993). On population and individual bioequivalence. Statistics in Medicine 12 1109-1124.
48. Scheffé, H. (1959). The Analysis of Variance. Wiley, New York.
49. Schuirmann, D. J. (1987). A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. Journal of Pharmacokinetics and Biopharmaceutics 15 657-680.
50. Schuirmann, D. J. (1989). Confidence intervals for the ratio of two means from a crossover study. In Proceedings of the Biopharmaceutical Section 121-126. Amer. Statist. Assoc., Alexandria, VA.
51. Schuirmann, D. L. (1981). On hypothesis testing to determine if the mean of a normal distribution is contained in a known interval. Biometrics 37 617.
52. Sheiner, L. B. (1992). Bioequivalence revisited. Statistics in Medicine 11 1777-1788.
53. Stefansson, G., Kim, W. C. and HSU, J. C. (1988). On confidence sets in multiple comparisons. In Statistical Decision Theory and Related Topics TV (S. S. Gupta and J. O. Berger, eds.) 2 89-104. Springer, New York.
54. Wang, W. (1994). Optimal unbiased tests for bioequivalence in variability. Technical report, Cornell Univ.
55. WESTLAKE, W. J. (1973). The design and analysis of comparative blood-level trials. In Current Concepts in the Pharmaceutical Sciences, Dosage Form Design and Bioavailability (J. Swar-brick, ed.) 149-179. Lea and Febiger, Philadelphia.
56. WESTLAKE, W. J. (1976). Symmetric confidence intervals for bioequivalence trials. Biometrics 32 741-744.
57. WESTLAKE, W. J. (1981). Response to T.B.L. Kirkwood: bioequivalence testing-a need to rethink. Biometrics 37 589-594.
58. WESTLAKE, W. J. (1988). Bioavailability and bioequivalence of pharmaceutical formulations. In Biopharmaceutical Statistics for Drug Development (Karl E. Peace, ed.) 329-352. Dekker, New York.
59. Yang, H.-M. (1991). An extended two one-sided tests procedure. In Proceedings of the Biopharmaceutical Section 157-162. Amer. Statist. Assoc., Alexandria, VA.
60. Yee, K. F. (1986). The calculation of probabilities in rejecting bioequivalence. Biometrics 42 961-965.
61. Yee, K. F. (1990). Correspondence to the Editor. The Statistician 39 465-466.